Telehealth providers in Ohio
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
Telehealth prescribing is allowed in Ohio, including asynchronous care. What Ohio requires of telehealth prescribers and pharmacies, plus listings with their verification status.
Ohio at a glance
- Pharmacy regulator
- State of Ohio Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async allowed
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Telehealth providers serving Ohio
Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.
Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Ohio (not yet confirmed)
- Prescription only, no research-use-only sales
- Public cancellation and refund policy
We may earn a commission from these links.
Telehealth prescribing rules in Ohio
ORC 4743.09 (originally enacted by House Bill 122, effective March 23, 2022; current version effective April 9, 2025) lets licensed health care professionals provide telehealth services, including initial and annual visits, using synchronous or asynchronous technology when the appropriate standard of care for the visit is satisfied. The State Medical Board's rule OAC 4731-37-01 (effective February 28, 2023) applies this to physicians and physician assistants, holds telehealth to the in-person standard of care, permits synchronous or asynchronous communication technology if that standard can be met for the patient's condition, requires a medical evaluation completed through interaction with the patient, and allows non-controlled prescription drugs to be prescribed through telehealth under the rule's requirements. The prescriber must hold an Ohio license. None of the peptides in this database are controlled substances. This record classifies asynchronous prescribing as allowed because both the statute and the Medical Board rule expressly permit asynchronous technology for an initial visit and the rule permits non-controlled prescribing through telehealth. Neither text says whether a questionnaire alone is enough. [2] [3]
Compounded GLP-1 access in Ohio
Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient specific needs because the FDA shortage allowances ended in 2025, and the Ohio Board of Pharmacy's July 2025 GLP-1 FAQs reinforce that copies of the approved products are not routinely compoundable in Ohio. Ohio's telehealth rule permits asynchronous technology when the in-person standard of care can be met and requires a medical evaluation completed through interaction with the patient. [3] [4] [9]
Research use only sellers in Ohio
ORC chapter 4729 restricts the sale and distribution of dangerous drugs to licensed pharmacies, distributors, and prescribers, and the Board reminds licensees to verify that sellers are licensed. Board guidance for prescriber clinics and medical spas (updated December 8, 2025) says any drug labeled for research purposes only is unlawful for a clinic or med spa to possess, even with patient consent, and must be disposed of immediately, with patients advised to stop using it. [1] [5] [10] [11]
How to check a telehealth provider in Ohio
- Confirm the prescriber is licensed or registered to treat patients located in Ohio; the telehealth rules above explain what Ohio requires. [2] [3]
- Ask which pharmacy will fill the prescription and check it in the State of Ohio Board of Pharmacy license lookup. [1] [4] [5] [6] [7] [8] [12]
- Get the full price in writing first: consult fees, membership fees, and the medication itself.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Ohio. [1] [5] [10] [11]
Common questions in Ohio
Can I get a GLP-1 prescription in Ohio through asynchronous telehealth?
Yes, if the prescriber holds an Ohio license and the in-person standard of care can be met. ORC 4743.09 and OAC 4731-37-01 allow synchronous or asynchronous technology, including for initial visits, and non-controlled drugs like semaglutide may be prescribed through telehealth. The rule also requires a medical evaluation completed through interaction with the patient. Neither text says whether a questionnaire alone is enough. [2] [3]
Sources
- [1]State of Ohio Board of Pharmacy
- [2]Ohio Revised Code 4743.09, Telehealth services
- [3]Ohio Administrative Code 4731-37-01, Telehealth (State Medical Board of Ohio)
- [4]State of Ohio Board of Pharmacy: Compounding of GLP-1 drug products in Ohio, guidance and FAQs (issued July 17, 2025)
- [5]Ohio Revised Code chapter 4729, Pharmacists; dangerous drugs
- [6]Ohio Revised Code 4729.54, Terminal distributor licenses
- [7]Ohio Administrative Code 4729:5-8-02, Non-resident pharmacies: licensure
- [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [10]21 U.S.C. 331, Prohibited acts
- [11]Ohio Board of Pharmacy: Ten Common Prescriber Clinic and Medical Spa Violations (updated 12/8/2025)
- [12]Ohio Board of Pharmacy: Responsible Person Requirements for Licensure (updated 9/10/2026)